Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Johnson

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Leukemia|August 31, 2013
The murine long-term multi-lineage renewal marrow stem cell is a cycling cellL R Goldberg, M S Dooner, K W Johnson, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2004
Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitorM Gross, J Clements, R P Beckett, et al.
British Journal of Pharmacology|February 10, 2015
A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasationK Hoehlig, K W Johnson, E Pryazhnikov, et al.
Brain, Behavior, and Immunity|October 7, 2008
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapyEvan Sloane, A Ledeboer, W Seibert, et al.
Biosensors & Bioelectronics|January 1, 1992
In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissueK W Johnson, J J Mastrototaro, D C Howey, et al.
Neuroreport|July 7, 1997
5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigsK W Johnson, J M Schaus, M M Durkin, et al.
Life Sciences|January 1, 1997
Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraineL A Phebus, K W Johnson, J M Zgombick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a)V M Morales, A Christ, S M Watt, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Journal of Medicinal Chemistry|November 16, 2001
N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapyY C Xu, K W Johnson, L A Phebus, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Leukemia|August 31, 2013
The murine long-term multi-lineage renewal marrow stem cell is a cycling cellL R Goldberg, M S Dooner, K W Johnson, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2004
Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitorM Gross, J Clements, R P Beckett, et al.
British Journal of Pharmacology|February 10, 2015
A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasationK Hoehlig, K W Johnson, E Pryazhnikov, et al.
Brain, Behavior, and Immunity|October 7, 2008
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapyEvan Sloane, A Ledeboer, W Seibert, et al.
Biosensors & Bioelectronics|January 1, 1992
In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissueK W Johnson, J J Mastrototaro, D C Howey, et al.
Neuroreport|July 7, 1997
5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigsK W Johnson, J M Schaus, M M Durkin, et al.
Life Sciences|January 1, 1997
Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraineL A Phebus, K W Johnson, J M Zgombick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a)V M Morales, A Christ, S M Watt, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Journal of Medicinal Chemistry|November 16, 2001
N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapyY C Xu, K W Johnson, L A Phebus, et al.
Pageof 8